The treatment option of progressive disease in breast cancer during neoadjuvant chemotherapy: a single-center experience

Patients’ responses to breast cancer neoadjuvant chemotherapy (NACT) differ because of heterogeneous tumor characteristics. Reports about NACT progression are sporadic. Here we enrolled 1187 patients who received NACT in our cancer center between January 1, 2007, and December 31, 2016. We analyzed t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Biol Ther
Main Authors: Zheng, Yurong, Ding, Xiaowen, Zou, Dehong, Zhang, Fanrong, Qin, Chengdong, Yang, Hongjian, Mo, Wenju, Ding, Yuqin, Yu, Yang
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2020
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7515534/
https://ncbi.nlm.nih.gov/pubmed/32420815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2020.1756707
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados